Caricamento...
A Novel Immunoassay for the Quantization of CYFRA 21–1 in Human Serum
BACKGROUND: Cytokeratin 19 fragment antigen (CYFRA 21–1) is used to diagnose and monitor neoplasms. However, the main disadvantages of the currently available CYFRA 21–1 assays include heterogenous technology, being time‐consuming, and having low through‐put with low insensitivity. This study invest...
Salvato in:
| Pubblicato in: | J Clin Lab Anal |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6807541/ https://ncbi.nlm.nih.gov/pubmed/23852784 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcla.21597 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|